CCO Infectious Disease Podcast

Key HIV Studies Influencing My Practice Following HIVR4P 2024—Drs . Linda-Gail Bekker and Meredith Clement

Episode Summary

Hear from Meredith E. Clement, MD, and Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD, as they discuss their insights on some of the most clinically relevant new data presented at HIVR4P 2024, covering studies on investigational PrEP options and strategies to improve PrEP implementation and uptake.

Episode Notes

In this rapid webinar, Meredith E. Clement, MD, and Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD, provide an overview of important topics and studies presented at HIVR4P 2024, including:

• Expanding PrEP options based on results from PURPOSE 2, IMPOWER-22, IMPOWER-24, IPM 054, MTN-025/HOPE OLE, CATALYST, and the HPTN 084 substudy
• Implementing injectable PrEP based on results from PEPFAR, the USAID DISCOVER-Health LA CAB Demonstration Project in Zambia, and the LA CAB PrEP Rapid Start Model in Public Health Clinics
• Improving PrEP uptake based on results from SPrEP and HPTN 091 

Presenters:

Meredith E. Clement, MD
Associate Professor
Infectious Diseases
Louisiana State University Health Sciences Center
New Orleans, Louisiana

Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
Director and Professor, The Desmond Tutu HIV Centre, UCT
CEO, The Desmond Tutu Health Foundation
Cape Town, South Africa

To access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. 

Link to full program: 
https://bit.ly/3NJIDSA